Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: ALLI
Active substances:
Estonian, English, Latin
ATC code: A08AB01
Dosage form: chewable tablet
Strength: 27mg
Legal status for supply*: Not subject to medicinal prescription
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Indication: alli is indicated for weight loss in adults who are overweight (body mass index, BMI, >=28 kg/m2) and should be taken in conjunction with a mildly hypocaloric, lower-fat diet.
Safety features: No
Marketing authorization holder: GlaxoSmithKline Dungarvan Limited 
Marketing authorization number: EU/1/07/401 
Marketing authorization issued on: July 25, 2012 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1506473  ALLI  chewable tablet  27mg 42TK  OTC           
1506484  ALLI  chewable tablet  27mg 60TK  OTC           
1506495  ALLI  chewable tablet  27mg 84TK  OTC           
1506507  ALLI  chewable tablet  27mg 90TK  OTC           
1538715  ALLI  chewable tablet  27mg 120TK  OTC           
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere